BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32318126)

  • 1. Special Staining of the Liquid-Based Cytopathology Test in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis with Nonneutropenic Patients.
    Hu Y; Zheng L; Pan D; Shao L; Xu X; Yu Y; Zhuang Q; Deng Z; Chen Z
    Can Respir J; 2020; 2020():8243473. PubMed ID: 32318126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchoalveolar Lavage Fluid Cytology in Culture-Documented Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases: Analysis of 67 Episodes.
    Fernández-Cruz A; Magira E; Heo ST; Evans S; Tarrand J; Kontoyiannis DP
    J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30021823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing the performance of a prototype lateral flow device using bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in high-risk patients.
    Castillo CG; Kauffman CA; Zhai J; Jiang H; Agozino SM; Miceli MH
    Mycoses; 2018 Jan; 61(1):4-10. PubMed ID: 28905439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
    Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
    Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan.
    de Mol M; de Jongste JC; van Westreenen M; Merkus PJ; de Vries AH; Hop WC; Warris A; Janssens HM
    Pediatr Pulmonol; 2013 Aug; 48(8):789-96. PubMed ID: 22949309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.
    Johnson GL; Sarker SJ; Nannini F; Ferrini A; Taylor E; Lass-Flörl C; Mutschlechner W; Bustin SA; Agrawal SG
    J Clin Microbiol; 2015 Jul; 53(7):2103-8. PubMed ID: 25903568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic role of polymerase chain reaction in bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in immunocompromised patients - A retrospective cohort study.
    Hardak E; Fuchs E; Leskes H; Geffen Y; Zuckerman T; Oren I
    Int J Infect Dis; 2019 Jun; 83():20-25. PubMed ID: 30926540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.
    Danpornprasert P; Foongladda S; Tscheikuna J
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S86-93. PubMed ID: 20364562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical application of Aspergillus lateral flow device in bronchoalveolar lavage fluid of patients with classic risk factors for invasive pulmonary aspergillosis.
    Linder KA; Kauffman CA; Zhou S; Miceli MH
    Mycoses; 2019 Dec; 62(12):1189-1193. PubMed ID: 31581342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
    Nguyen MH; Leather H; Clancy CJ; Cline C; Jantz MA; Kulkarni V; Wheat LJ; Wingard JR
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
    Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
    Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients.
    Eigl S; Prattes J; Lackner M; Willinger B; Spiess B; Reinwald M; Selitsch B; Meilinger M; Neumeister P; Reischies F; Wölfler A; Raggam RB; Flick H; Eschertzhuber S; Krause R; Buchheidt D; Thornton CR; Lass-Flörl C; Hoenigl M
    Crit Care; 2015 Apr; 19(1):178. PubMed ID: 25927915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchoalveolar lavage fluid polymerase chain reaction for invasive pulmonary aspergillosis among high-risk patients: a diagnostic meta-analysis.
    Han Y; Wu X; Jiang G; Guo A; Jin Z; Ying Y; Lai J; Li W; Yan F
    BMC Pulm Med; 2023 Feb; 23(1):58. PubMed ID: 36750828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of PCR alone compared to galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis: a systematic review.
    Avni T; Levy I; Sprecher H; Yahav D; Leibovici L; Paul M
    J Clin Microbiol; 2012 Nov; 50(11):3652-8. PubMed ID: 22952268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchoalveolar galactomannan in invasive pulmonary aspergillosis: a prospective study in pediatric patients.
    Mohammadi S; Khalilzadeh S; Goudarzipour K; Hassanzad M; Mahdaviani A; Aarabi N; Pourabdollah M; Sigari N
    Med Mycol; 2015 Sep; 53(7):709-16. PubMed ID: 26229150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and optimization of quantitative PCR for the diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.
    Khot PD; Ko DL; Hackman RC; Fredricks DN
    BMC Infect Dis; 2008 May; 8():73. PubMed ID: 18510764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies.
    Luong ML; Filion C; Labbé AC; Roy J; Pépin J; Cadrin-Tourigny J; Carignan S; Sheppard DC; Laverdière M
    Diagn Microbiol Infect Dis; 2010 Oct; 68(2):132-9. PubMed ID: 20846585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis.
    Boch T; Buchheidt D; Spiess B; Miethke T; Hofmann WK; Reinwald M
    Mycoses; 2016 Feb; 59(2):80-5. PubMed ID: 26627577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a new Aspergillus real-time PCR assay for direct detection of Aspergillus and azole resistance of Aspergillus fumigatus on bronchoalveolar lavage fluid.
    Chong GL; van de Sande WW; Dingemans GJ; Gaajetaan GR; Vonk AG; Hayette MP; van Tegelen DW; Simons GF; Rijnders BJ
    J Clin Microbiol; 2015 Mar; 53(3):868-74. PubMed ID: 25568431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the clinical utility of reflex GMS and AFB stains on BAL specimens from lung transplant patients.
    Torous VF; Pitman MB; Ly A
    J Am Soc Cytopathol; 2020; 9(3):166-172. PubMed ID: 32179025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.